Innovation as a National Priority: The Key to a Sustainable Healthcare System At Astellas, we believe that innovation in biopharmaceuticals is not a luxury – it is a necessity in today’s ever-evolving healthcare landscape. Innovation has revolutionized the way we detect, treat, and manage diseases. From rare genetic disorders to chronic illnesses such as cancer,…
A Healthcare System that Encourages Innovation – A Shared Responsibility for Greece’s Future At Amgen Hellas, we serve a clear purpose: to improve patients’ quality of life by harnessing the power of science. We firmly believe that every citizen in Greece deserves equal and timely access to innovative treatments—therapies that not only extend life, but…
Greece in the Era of EHDS: A Dialogue on Innovation in Cancer Care The inaugural “My Data, Our Health” workshop, co-organized by Pharma Innovation Forum (PIF) and the Hellenic Cancer Federation (ELLOK), marked the beginning of a national dialogue on building a cohesive strategy for the responsible use of health data in Greece. As the…
Labrina Barmpetaki, President of PIF: “Harnessing medical data is essential for a fair and sustainable pharmaceutical policy.” Through targeted interventions and a clear, strategic message, PhARMA Innovation Forum (PIF) actively participated in the 6th Health Conference organized by Proto Thema. Labrina Barmpetaki, joined the panel discussion entitled “Shaping a National Pharmaceutical Policy: Prerequisites and Challenges.”…
Labrina Barmpetaki, President of PIF: “Innovation is the future of pharmaceutical policy.” Pharmaceutical innovation took center stage at the 10th Delphi Economic Forum, with Pharma Innovation Forum (PIF) participating in the panel titled “Safeguarding Innovation, Fueling Growth and Social Prosperity.” Representatives from the Goverment and the pharmaceutical industry — including the Minister of Health Mr.…
Labrina Barmpetaki, President of PIF: “The patient cannot wait. Access to the right treatment, at the right time, must be our common goal.” PhARMA Innovation Forum Greece highlights the value of innovation in health, aiming at the immediate implementation of solutions to address cancer challenges at the 9th ELLOK Conference PhARMA Innovation Forum…
Pharma Innovation Forum Greece highlights the value of innovation at the National Congress of the Hellenic Association of Health Economics. Pharma Innovation Forum (PIF) and its members continue to lead the public dialogue on health, focusing on promoting pharmaceutical innovation as a pillar of sustainability and equitable access to innovative treatments. The General Secretary of…
Letter from PIF & AMCHAM Pharma Committee to the Prime Minister: Dear Prime Minister, At this particularly critical juncture for the pharmaceutical industry, we address you as the Board of Directors of PhARMA Innovation Forum (PIF) and the Committee of Pharmaceutical Companies of the American-Hellenic Chamber of Commerce, to express our deep concern about…
Fewer than 2 out of 10 treatments are covered by the state, severely limiting patients’ access to innovative and critical therapies. Following the meeting between the Minister of Health, Mr. Adonis Georgiadis, and the pharmaceutical industry associations, the issue of mandatory clawback payments for the first half of 2023 is being hastily addressed, with the…
PhARMA Innovation Forum (PIF) and its 26 biopharmaceutical member companies express their deep concern over the impasse regarding patient access to innovative therapies. According to official data from the National Central Purchasing Body for Health Sector (EKAPY), shared with our companies and covering the first half of 2023, the mandatory clawbacks due to budget overruns…
